Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alcon Inc. Ordinary Shares
(NY:
ALC
)
88.96
+2.15 (+2.48%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Alcon Inc. Ordinary Shares
< Previous
1
2
3
Next >
Alcon to Host 2025 Capital Markets Day
March 13, 2025
From
Alcon Inc. Investors
Via
Business Wire
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
February 27, 2025
From
Alcon Canada
Via
Business Wire
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
February 25, 2025
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
February 24, 2025
From
Alcon Inc. Investors
Via
Business Wire
Alcon Inc. (NYSE: ALC) Records 52-Week High Tuesday Morning
March 12, 2024
Via
Investor Brand Network
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
February 19, 2025
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
December 31, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
November 12, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Inc. (NYSE: ALC) Highlighted for Surprising Price Action
August 17, 2023
Via
Investor Brand Network
Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
November 07, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
October 15, 2024
From
Alcon Inc. Investors
Via
Business Wire
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
September 25, 2024
The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.
Via
MarketBeat
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
August 20, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
June 24, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
May 13, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2024 Annual General Meeting
May 08, 2024
From
Alcon Inc. Investors
Via
Business Wire
Star Surgical Shines as U.S. Outlook Improves for 2024
April 16, 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population
Via
MarketBeat
Alcon Publishes Agenda for 2024 Annual General Meeting
April 07, 2024
From
Alcon Inc. Investors
Via
Business Wire
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
March 06, 2024
From
Alcon Inc. Corporate
Via
Business Wire
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
February 27, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
January 09, 2024
From
Alcon Inc. Investors
Via
Business Wire
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 05, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Third Quarter 2023 Results
November 14, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
October 30, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
October 10, 2023
From
Alcon Inc. Investors
Via
Business Wire
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
September 09, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
September 06, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports Second Quarter 2023 Results
August 15, 2023
From
Alcon Inc. Investors
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.